文献速递心境障碍会诊联络精神医学

疼痛性躯体症状与抑郁症抗抑郁治疗结局的系统综述与荟萃分析

Painful physical symptoms and antidepressant treatment outcome in depression: a systematic review and meta-analysis.
PubMed 文献 · Mol Psychiatry · 2024-03-13

该系统综述与荟萃分析纳入20项原始研究,评估基线疼痛水平与重性抑郁障碍(MDD)患者抗抑郁治疗反应/缓解的关联。结果显示,治疗无反应者基线疼痛严重度、疼痛干扰及疼痛性躯体症状(PPS)存在率均显著更高,PPS与治疗无缓解显著相关。提示PPS与抗抑郁治疗结局负相关,改善疼痛可能有助于提升疗效。

要点

  • MDD治疗无反应者基线疼痛严重度显著高于有反应者(Hedge's g=0.32)。
  • 基线PPS存在与治疗反应差显著相关(OR=1.46),与无缓解显著相关(OR=1.70)。
  • 治疗无反应者基线疼痛干扰显著更高(Hedge's g=0.46)。

核心结论

  • 疼痛性躯体症状与MDD患者抗抑郁治疗结局呈负相关。
  • 治疗抑郁时更好地管理疼痛状况可能有益于抗抑郁药物的治疗效果。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase和Cochrane Library数据库自建库至2023年2月,方案预注册于PROSPERO(CRD42022381349)。
  • 纳入报告MDD患者抗抑郁治疗前疼痛测量与治疗反应/缓解结局的原始研究,共纳入20项研究。
  • 采用随机效应荟萃分析计算效应量(Hedge's g),并进行亚组分析和荟萃回归探索异质性来源。

主要发现

  • 6项研究报告MDD治疗无反应者基线疼痛严重度显著更高(Hedge's g=0.32;95%CI 0.13-0.51;P=0.0008)。
  • 6项研究报告PPS存在(采用疼痛严重度量表测量)与治疗反应差显著相关(OR=1.46;95%CI 1.04-2.04;P=0.028)。
  • 5项研究报告无反应者基线疼痛干扰水平显著更高(Hedge's g=0.46;95%CI 0.32-0.61;P<0.0001)。
  • 4项研究发现未缓解者基线疼痛严重度显著更高(Hedge's g=0.27;95%CI 0.14-0.40;P<0.0001)。
  • 8项研究报告PPS存在与治疗未缓解显著相关(OR=1.70;95%CI 1.24-2.32;P=0.0009)。

关键数值与推荐

  • 基线疼痛严重度:无反应者 vs 有反应者 Hedge's g=0.32(95%CI 0.13-0.51;P=0.0008),基于6项研究。
  • PPS存在与治疗反应差:OR=1.46(95%CI 1.04-2.04;P=0.028),基于6项研究。
  • 基线疼痛干扰:无反应者 vs 有反应者 Hedge's g=0.46(95%CI 0.32-0.61;P<0.0001),基于5项研究。
  • 基线疼痛严重度:未缓解者 vs 缓解者 Hedge's g=0.27(95%CI 0.14-0.40;P<0.0001),基于4项研究。
  • PPS存在与治疗未缓解:OR=1.70(95%CI 1.24-2.32;P=0.0009),基于8项研究。

临床怎么用

  • 在MDD抗抑郁治疗前评估疼痛性躯体症状及疼痛干扰水平,可能有助于识别治疗反应不佳风险较高的患者。
  • 对伴有疼痛性躯体症状的MDD患者,在抗抑郁治疗中考虑同步加强疼痛管理,可能改善治疗结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Painful physical symptoms (PPS) are highly prevalent in patients with major depressive disorder (MDD). Presence of PPS in depressed patients are potentially associated with poorer antidepressant treatment outcome. We aimed to evaluate the association of baseline pain levels and antidepressant treatment outcomes. METHODS: We searched PubMed, Embase and Cochrane Library databases from inception through February 2023 based on a pre-registered protocol (PROSPERO: CRD42022381349). We included original studies that reported pretreatment pain measures in antidepressant treatment responder/remitter and non-responder/non-remitter among patients with MDD. Data extraction and quality assessment were performed following the Preferred Reporting Items for Systematic Reviews and Meta-analyses by two reviewers independently. The primary outcome was the difference of the pretreatment pain levels between antidepressant treatment responder/remitter and non-responder/non-remitter. Random-effects meta-analysis was used to calculate effect sizes (Hedge's g) and subgroup and meta-regression analyses were used to explore sources of heterogeneity. RESULTS: A total of 20 studies were included. Six studies reported significantly higher baseline pain severity levels in MDD treatment non-responders (Hedge's g = 0.32; 95% CI, 0.13-0.51; P = 0.0008). Six studies reported the presence of PPS (measured using a pain severity scale) was significantly associated with poor treatment response (OR = 1.46; 95% CI, 1.04-2.04; P = 0.028). Five studies reported significant higher baseline pain interference levels in non-responders (Hedge's g = 0.46; 95% CI, 0.32-0.61; P < 0.0001). Four studies found significantly higher baseline pain severity levels in non-remitters (Hedge's g = 0.27; 95% CI, 0.14-0.40; P < 0.0001). Eight studies reported the presence of PPS significantly associated with treatment non-remission (OR = 1.70; 95% CI, 1.24-2.32; P = 0.0009). CONCLUSIONS: This study suggests that PPS are negatively associated with the antidepressant treatment outcome in patients with MDD. It is possible that better management in pain conditions when treating depression can benefit the therapeutic effects of antidepressant medication in depressed patients.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liu JJ, Huang X, Bao YP, et al. Painful physical symptoms and antidepressant treatment outcome in depression: a systematic review and meta-analysis. Mol Psychiatry. 2024. PMID: 38480874. doi:10.1038/s41380-024-02496-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。